[Clinical efficacy of TS-1 in refractory bone recurrence of a postoperative squamous lung cancer patient].
Gan To Kagaku Ryoho
; 33(8): 1119-23, 2006 Aug.
Article
em Ja
| MEDLINE
| ID: mdl-16912531
ABSTRACT
BACKGROUND:
We need more effective treatments for refractory non-small cell lung cancer. CASE A 61-year-old man had a recurrence in the left ninth rib invading the chestwall 4 years after resection of squamous cell lung cancer. The metastatic lesion grew larger even after 3 different regimens of systemic chemotherapy and local irradiation. Then he started to receive 120 mg of TS-1 daily for 28 days followed by 14 days of rest (1 course). A partial response was achieved after 2 courses of the treatment and continued for 6 weeks. Doses of oxycodone hydrochloride could be reduced to one-sixth of the initial dose according to tumor regression.CONCLUSION:
This is the first report to show the effectiveness of TS-1 for a refractory recurrence of lung cancer to the bone.
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Ácido Oxônico
/
Costelas
/
Neoplasias Ósseas
/
Carcinoma de Células Escamosas
/
Tegafur
/
Neoplasias Pulmonares
/
Antimetabólitos Antineoplásicos
Limite:
Humans
/
Male
/
Middle aged
Idioma:
Ja
Revista:
Gan To Kagaku Ryoho
Ano de publicação:
2006
Tipo de documento:
Article